News & Events

News & Events

Press Releases

December 01, 2025
Encoded Therapeutics to Present Interim Phase 1/2 Clinical Data on ETX101, the First One-time Gene Therapy in Development for Dravet Syndrome, at the 2025 American Epilepsy Society Annual Meeting
October 09, 2025
New Preclinical Data from Encoded Therapeutics Demonstrate Therapeutic Potential of its One-time, Non-opioid Gene Therapy Candidate for Chronic Pain
September 02, 2025
Encoded Therapeutics Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for ETX101 in SCN1A+ Dravet Syndrome
View All Press Releases

In the Code Blog

RARECast podcast: Differentiating Gene Therapies through Regulatory Elements
June 03, 2024
RARECast podcast: Differentiating Gene Therapies through Regulatory Elements
Read Full Article
Our platform to discover and validate regulatory elements to drive targeted transgene expression for use in gene therapies
October 24, 2023
Our platform to discover and validate regulatory elements to drive targeted transgene expression for use in gene therapies
Read Full Article
Building Customized Gene Expression Profiles
October 13, 2022
Building Customized Gene Expression Profiles
Read Full Article
View All Blog Articles

Media Kit

Logo

Media Kit - Logos

Leadership Photos

Kartik Ramamoorthi, Ph.D.
Kartik Ramamoorthi, Ph.D.
Encoded Co-Founder, CEO and Board Member
Stephanie Tagliatela
Stephanie Tagliatela
Encoded Co-Founder, Chief Scientific Officer and Board Member
Salvador Rico, M.D., Ph.D.
Salvador Rico, M.D., Ph.D.
Encoded Chief Medical Officer

Photos

Encoded lab coat
Encoded lab coat
Encoded Therapeutics headquarters in South San Francisco
Encoded Therapeutics headquarters in South San Francisco
Scientists in Encoded’s sequencing lab
Scientists in Encoded’s sequencing lab
Scientist in Encoded’s lab
Scientist in Encoded’s lab
Scientist in Encoded’s lab
Scientist in Encoded’s lab
Scientist in Encoded’s lab
Scientist in Encoded’s lab
Download Photo Archive

Video Footage

Media Kit - Footage